CN Stock MarketDetailed Quotes

Beijing Leadman Biochemistry (300289)

Watchlist
  • 6.23
  • +0.11+1.80%
Market Closed May 22 15:00 CST
3.39BMarket Cap-132.55P/E (TTM)

Beijing Leadman Biochemistry (300289) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
In vitro diagnostic reagent240.11M73.59%
house lease38.53M11.81%
Diagnostic instrument32.28M9.89%
Biochemical raw materials13.24M4.06%
Service2.14M0.66%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological and pharmaceutical products285.64M87.54%
house lease38.53M11.81%
Service2.14M0.66%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region135.61M41.56%
North China80M24.52%
South China41.65M12.76%
Central China38.49M11.80%
Northeast area13.83M4.24%
Southwest area8.67M2.66%
Northwest region8.06M2.47%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More